These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6334232)

  • 1. Immunologic and functional characterization of anti-HLA-DR rabbit antibodies induced by synthetic peptides.
    Chersi A; Schulz G; Houghten RA
    Mol Immunol; 1984 Oct; 21(10):847-52. PubMed ID: 6334232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and isolation of antibodies to human MHC class II alpha chains by aid of synthetic peptides.
    Chersi A; Romano TF; Chillemi F
    Z Naturforsch C J Biosci; 1989; 44(9-10):813-8. PubMed ID: 2590343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of HLA class II molecules by antipeptide antibodies elicited by synthetic peptides selected from regions of HLA-DP antigens.
    Chersi A; Houghten RA; Morganti MC; Muratti E
    Z Naturforsch C J Biosci; 1987; 42(11-12):1313-8. PubMed ID: 2966503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.
    De Kretser TA; Crumpton MJ; Bodmer JG; Bodmer WF
    Eur J Immunol; 1982 Jul; 12(7):600-6. PubMed ID: 6811289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activity of antibodies to human Ia-like determinants: comparison of intact and pepsin-digested antibodies.
    Muchmore AV; Megson M; Decker JM; Knudsen P; Mann DL; Broder S
    J Immunol; 1983 Aug; 131(2):725-30. PubMed ID: 6408187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus-specific detection of HLA-DQ and -DR antigens by antibodies against synthetic N-terminal octapeptides of the beta chain.
    Deufel T; Grove A; Kofod H; Lernmark A
    FEBS Lett; 1985 Sep; 189(2):329-37. PubMed ID: 2995123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides.
    Chersi A; Morganti MC; Chillemi F; Houghten R; Cenciarelli C
    Clin Exp Immunol; 1988 Jul; 73(1):76-81. PubMed ID: 3168331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules.
    Crepaldi T; Richiardi P; Malavasi F; Carbonara AO; Igarashi M; Ferrone S
    Tissue Antigens; 1985 Jul; 26(1):25-34. PubMed ID: 2412306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned immunization of human volunteers with HLA-DR incompatible lymphocytes I. Serological aspects.
    Madsen M; Johnsen HE; Kristensen T; Jørgensen F; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1982 Jul; 20(1):33-46. PubMed ID: 6957026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
    Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
    J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of anti-MHC class II antibody binding to synthetic peptides.
    Chersi A; Romano TF; Ruocco E
    Z Naturforsch C J Biosci; 1989; 44(9-10):886-9. PubMed ID: 2590345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.
    Busch R; Strang G; Howland K; Rothbard JB
    Int Immunol; 1990; 2(5):443-51. PubMed ID: 1707655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced T cell responses to antigenic peptides targeted to B cell surface Ig, Ia, or class I molecules.
    Casten LA; Kaumaya P; Pierce SK
    J Exp Med; 1988 Jul; 168(1):171-80. PubMed ID: 2840479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies directed against HLA-DR gene products exhibit the CYNAP phenomenon.
    Gebel HM; Oldfather JW; Karr RW; Fuller TC; Rodey GE
    Tissue Antigens; 1984 Mar; 23(3):135-40. PubMed ID: 6427971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of linear HLA class II amino acid sequences recognized by rabbit antisera against native molecules.
    Chersi A; Morganti MC; Houghten R; Chillemi F; Muratti E
    Scand J Immunol; 1987 Dec; 26(6):723-9. PubMed ID: 2447636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to HLA--DRw determinants.
    Brodsky FM; Parham P; Bodmer WF
    Tissue Antigens; 1980 Jul; 16(1):30-48. PubMed ID: 6162228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.